Nephrologists' perspectives on cancer screening in patients with chronic kidney disease: An interview study

James, Laura; Wong, Germaine; Craig, Jonathan C.; Howard, Kirsten; Howell, Martin; Tong, Allison

doi:10.1111/nep.13269

Cited by 4 publications

(2 citation statements)

References 30 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Therefore, this could have resulted in selection bias. In addition, the likelihood of cancer screening may be different in CKD patients compared to the general population [32,33], which could have also introduced sample bias. This is particularly possible for malignancies such as thyroid cancer in which screening behavior affects its incidence [34].…”

Section: Discussionmentioning

confidence: 99%

Risk of cancer in pre-dialysis chronic kidney disease: A nationwide population-based study with a matched control group

Park

Lee

Kim

et al. 2019

Kidney Res Clin Pract.

View full text Add to dashboard Cite

Background Cancer risk and epidemiology in pre-dialysis chronic kidney disease (CKD) warrant further investigation in a large-scale cohort. Methods We performed a nationwide population-based study using the national health insurance database of Korea. We screened records from 18,936,885 individuals who received a national health examination ≥ 2 times from 2009 to 2016. Pre-dialysis CKD was identified based on serum creatinine and dipstick albuminuria results. Individuals with preexisting cancer history, renal replacement therapy, or transient CKD were excluded. A control group without evidence of kidney function impairment and matched for age, sex, low-income status, and smoking history was included. Risk of cancers, as identified in the claims database, was investigated using a multivariable Cox regression model including matched variables and other unmatched clinical characteristics as covariates. Results A total of 471,758 people with pre-dialysis CKD and the same number of matched controls were included. Urinary (adjusted hazard ratio [HR], 1.97; 95% confidence interval [95% CI], 1.82–2.13) and hematopoietic (adjusted HR, 1.53; 95% CI, 1.38–1.68) malignancy risk was increased in pre-dialysis CKD and all CKD stages. However, the risk of digestive cancer was lower in the pre-dialysis CKD group (adjusted HR, 0.89; 95% CI, 0.87–0.92). The risk of digestive, respiratory, thyroid, and prostate malignancy demonstrated a non-linear association with CKD stage, with stage 1 or stage 4/5 CKD without dialysis demonstrating relatively lower risk. Conclusion Cancer risk varied in pre-dialysis CKD compared to controls, and the association between cancer risk and CKD stage varied depending on the cancer type.

show abstract

Section: Discussionmentioning

confidence: 99%

Risk of cancer in pre-dialysis chronic kidney disease: A nationwide population-based study with a matched control group

Park

Lee

Kim

et al. 2019

Kidney Res Clin Pract.

View full text Add to dashboard Cite

show abstract

“…10 For example, to inform a DCE on eliciting preferences for cancer screening in patients with chronic kidney disease, semistructured interviews were conducted with patients and clinicians covering the topics of knowledge of cancer screening, facilitators, barriers, and priorities for cancer screening. 27,28 In the analysis process (eg, thematic analysis), concepts or themes are inductively identified and compared. Using this approach, attributes and attribute levels are then identified and extrapolated from the data to use in the DCE.…”

Section: Qualitative Research To Identify Initial Attributesmentioning

confidence: 99%

Discrete Choice Experiments to Elicit Patient Preferences for Decision Making in Transplantation

et al. 2020

Self Cite

View full text Add to dashboard Cite

Providing care for transplant recipients is challenging given the need to maintain optimal graft function and survival while managing the debilitating side effects and complications associated with immunosuppression including infection, cancer, new-onset diabetes mellitus, and cardiovascular disease. Given the complexity of treatment options and the uncertainty about long-term benefits and harms of treatment, understanding patient preferences and values are key to ensuring that clinical decisions take into consideration patient priorities to support shared decision making and self-management. Choice experiments are increasingly used to quantify patient and community preferences, including in the field of transplantation. Discrete choice experiments (DCEs) are a well-established, validated methodology used to elicit preferences for decision making in health and other settings. In transplantation, for example, DCEs have been used to elicit patient preferences for outcomes following kidney transplantation, to identify community preferences factors for organ allocation and in establishing core outcomes. This article provides an overview of the concepts and methods used in the design of DCEs and how patients’ preferences can be applied in shared decision making in transplantation.

show abstract

Summary of the International Conference on Onco-Nephrology: an emerging field in medicine

Benigni

Małyszko

Capasso

et al. 2019

Kidney International

View full text Add to dashboard Cite

Onco-nephrology is an emerging field in medicine. Patients with cancer may suffer from kidney diseases because of the cancer itself and cancer-related therapy. It is critical for nephrologists to be knowledgeable of cancer biology and therapy in order to be fully integrated in the multidisciplinary team and optimally manage patients with cancer and kidney diseases. In a recent international meeting, the key issues in this challenging clinical interface were addressed, including many unresolved basic science questions, such as the high tumor incidence in kidney transplant recipients. To this end, 70 highly qualified faculty members were gathered from all over the world to discuss these issues in 8 plenary sessions, including 5 keynote lectures. In addition, 48 young nephrologists and oncologists were invited to present their original observations that were highlighted in 2 large poster sessions.

show abstract

Nephrologists' perspectives on cancer screening in patients with chronic kidney disease: An interview study

Cited by 4 publications

References 30 publications

Risk of cancer in pre-dialysis chronic kidney disease: A nationwide population-based study with a matched control group

Risk of cancer in pre-dialysis chronic kidney disease: A nationwide population-based study with a matched control group

Discrete Choice Experiments to Elicit Patient Preferences for Decision Making in Transplantation

Summary of the International Conference on Onco-Nephrology: an emerging field in medicine

Contact Info

Product

Resources

About